Neurology Clinical Trials in San Francisco, CA
As of July 2026, 54 paid clinical trials are recruiting for Neurology in San Francisco, California. Neurology trials investigate disease-modifying therapies for Alzheimer's, Parkinson's, multiple sclerosis, ALS, and stroke recovery alongside symptomatic treatments for epilepsy, migraine, and cognitive decline. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in San Francisco
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Comprehensive Digital Care Program for Migraine Management
Recovery Trajectory for Coma and Disorders of Consciousness
57 clinical trials for Neurology
·Clear filters·↓ Download CSVA Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
Study of Oral Ubrogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)
[18F]PI-2620 Phase 3 Histopathological Study
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
A Study to Develop a Blood-based Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adults and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Deep Brain Stimulation (DBS) Retrospective Outcomes Study
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
Hyperpolarized Carbon Metabolic Imaging in Multiple Sclerosis
Aphasia Physical EXercise Study: Randomized Trial
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
HEALEY ALS Platform Trial - Master Protocol
PREVENT ALL ALS Study
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Clinical Procedures to Support Research in ALS
ASSESS ALL ALS Study
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
A Study of Ranolazine in ALS
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
Understanding Motivation in Parkinson's Patients Through Neurophysiology
Psilocybin Therapy for Depression in Parkinson's Disease
Care in Multiple Sclerosis (MS)
Wayfinding Intervention and Long-Term Memory
ECoG BMI for Motor and Speech Control
BID LTM Digital Intervention in Aging
Ketamine for Veterans With Parkinson's Disease
"Selfie" Videos: A Novel, Patient-centered, Comprehensive Approach to Measuring Function in MS
BID WM Digital Intervention in Aging
Responding With Evidence and Access for Childhood Headaches
Ultrasound Neuromodulation in Essential Tremor
Enhancing Attention and Wellbeing Using Digital Therapeutics
Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
The Active Mind Trial: An Adaptive Randomized Trial to Improve Function and Delay Dementia
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
Pediatric Dose Optimization for Seizures in Emergency Medical Services
Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance
About research studies in San Francisco
San Francisco has approximately 1,362 recruiting research studies across a wide range of therapeutic areas. California hosts a dense network of world-class research institutions, including UC San Diego Health, Stanford Medicine, UCLA Health, UCSF, City of Hope, and Scripps Research. The state's thriving biotech corridor and diverse patient population make it a national hub for both early-phase and late-phase clinical research.
Top Research Study Locations in San Francisco
Researchers run research studies in San Francisco, CA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of California, San Francisco | Prostate Cancer, Glioblastoma, Amyotrophic Lateral Sclerosis | 321 |
| University of California San Francisco | Multiple Myeloma, Breast Cancer, Primary Immune Deficiency Disorder | 163 |
| Power Life Sciences | Acne, Anorexia, Anorexia Nervosa | 61 |
| UCSF Medical Center-Mission Bay | B Acute Lymphoblastic Leukemia, Neuroblastoma, Recurrent Malignant Solid Neoplasm | 38 |
| Kaiser Permanente-San Francisco | Stage IV Lung Cancer AJCC v8, Breast Cancer, Lung Non-Small Cell Carcinoma | 34 |
| UCSF | Colorectal Cancer, Tricuspid Valve Disease, ADHD | 33 |
| Zuckerberg San Francisco General Hospital | Cardiovascular Diseases, HIV, Healthy | 25 |
| UCSF Helen Diller Family Comprehensive Cancer Center | Advanced Breast Cancer, Breast Cancer, Prostate Cancer | 23 |
| UCSF Medical Center | Stroke, Aneurysm, Aneurysm, Intracranial | 22 |
| California Pacific Medical Center-Pacific Campus | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma | 21 |
| University of California | Aortic Valve Regurgitation, Aortic Valve Stenosis, Articular Cartilage | 20 |
| San Francisco VA Medical Center, San Francisco, CA | PTSD, Sleep Initiation and Maintenance Disorders, Aging | 16 |
| University of California, San Francisco (UCSF) | Colorectal Cancer, Non-small Cell Lung Cancer, Acquired Resistance to KRAS G12C Inhibitor | 16 |
| California Pacific Medical Center | Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Melanoma | 13 |
| UCSF Benioff Children's Hospital | 4H Syndrome, ADLD, AGS | 13 |
| San Francisco General Hospital | HIV, HIV Infections, Intracerebral Hemorrhage | 12 |
| Alethios, Inc. | Beverage Intake, Caffeine, Healthy | 11 |
| San Francisco Research Institute | Women Health, Anxiety, Cognitive Decline | 10 |
| San Francisco VA Medical Center | Atopic Dermatitis, Eczema, Atopic Dermatitis (Eczema) | 10 |
| UCSF Medical Center-Parnassus | Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm, Acute Myeloid Leukemia Post Cytotoxic Therapy | 8 |
| University of California - San Francisco | Bladder Cancer, Diabetes, Diabetic Foot | 8 |
| University of California San Francisco (UCSF) | Melanoma, Advanced Solid Tumors, Angiosarcoma | 8 |
| University of California at San Francisco | Advanced Tumors, Aortic Valve Disease, Aortic Valve Stenosis | 8 |
| University of San Francisco | Cone Rod Dystrophy, Juvenile Macular Degeneration, Stargardt Disease | 7 |
| Sutter Health | Alzheimer Disease, Aortic Insufficiency, Aortic Regurgitation | 6 |
Active & Upcoming Studies in San Francisco (2026)
Recruiting trials in San Francisco grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (406 active studies)
- Prenatal Transplantation for Fetuses With Fanconi Anemia · Phase 1, Phase 2 · Agnieszka Czechowicz
- Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial · Phase 3 · National Cancer Institute (NCI)
Neurology & pain (84 active studies)
- Alzheimer's Tau Platform: Regimen A - AADvac1 · Phase 2 · Paul S. Aisen
- An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service · Phase 3 · University of California, San Francisco
Cardiovascular (83 active studies)
- Naloxone for Opioid Associated Out of Hospital Cardiac Arrest · Phase 2 · University of California, San Francisco
- A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. · P+F Products + Features USA Inc.
Mental health & behavior (49 active studies)
- Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject Drugs · University of California, San Francisco
- CBITS-RTM Pilot Study · University of California, San Francisco
HIV / STI (46 active studies)
- Liver Transplantation From Donors With HIV: Impact on Opportunistic Infections, Cancer, and Long-Term Outcomes (Expanding HOPE Liver) · Johns Hopkins University
- Pilot Study of an Adapted Partner Navigation Intervention Booster Session for Sustained Healthcare Engagement Among People Who Inject Drugs · University of California, San Francisco
Diabetes & metabolic (38 active studies)
- PRISE (Personalized Response and Immunologic Surveillance of Endogenous C-Peptide Preservation in New, Recent, and Established Onset Type 1 Diabetes Treated With Human Anti-Thymocyte Globulin [h-ATG]) Study · Phase 3 · University of Florida
- Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese · Phase 2 · Biomed Industries, Inc.
Pediatric (23 active studies)
- Prenatal Transplantation for Fetuses With Fanconi Anemia · Phase 1, Phase 2 · Agnieszka Czechowicz
- Building Relationship, Improving Dialogue, and Growing Empathy (BRIDGE): An Intervention to Support Decision Making for Critically Ill Children · Duke University
Eye & vision (19 active studies)
- Effect of Vision Centers on Access to Eye Care and Eye Health Outcomes · University of California, San Francisco
- Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center · University of California, San Francisco
Vaccines (13 active studies)
- Multiparametric [18F]F-AraG Imaging in Post-Acute Sequelae of COVID-19 (PASC) · EARLY_Phase 1 · University of California, Davis
- A Study to Assess Anktiva in Patients With Long Covid-19. · Phase 2 · ImmunityBio, Inc.
Common conditions studied in San Francisco
- Breast Cancer (27 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Prostate Cancer (27 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Heart Failure (17 active studies). Heart failure trials explore SGLT-2 inhibitors, novel myosin modulators, and device-based therapies for both reduced and preserved ejection fraction.
- HIV (15 active studies). HIV trials investigate long-acting injectable antiretrovirals, broadly neutralizing antibodies, and cure-focused strategies.
- Cancer (14 active studies). Recruiting Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Glioblastoma (13 active studies). Glioblastoma studies investigate tumor-treating fields, targeted small molecules, and immunotherapy combinations for this aggressive brain cancer.
Leading research sponsors in San Francisco
- University of California, San Francisco
- Power Life Sciences Inc.
- National Cancer Institute (NCI)
- Children's Oncology Group
- Merck Sharp & Dohme LLC
Local regulations and guidelines
Clinical trials in California are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. In addition, California-specific protections such as the California Consumer Privacy Act (CCPA) and the Confidentiality of Medical Information Act (CMIA) impose stringent data-privacy requirements on research involving California residents.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in San Francisco. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in San Francisco
Hipa.ai aggregates every recruiting study in San Francisco from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in San Francisco?
There are approximately 1,362 recruiting clinical trials in San Francisco, California listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in San Francisco pay participants?
Most recruiting trials in San Francisco compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in San Francisco?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in San Francisco?
The most common conditions under active study in San Francisco include Breast Cancer (27), Prostate Cancer (27), Heart Failure (17), HIV (15), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in San Francisco?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in San Francisco on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in San Francisco?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in San Francisco?
Recruiting research sites in San Francisco include University of California, San Francisco, University of California San Francisco, Power Life Sciences, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in San Francisco right now?
The largest active categories in San Francisco are Cancer & tumors (406), Neurology & pain (84), Cardiovascular (83). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.